EUVIMEDObjevte EUVIMED
ÜbersichtsarbeitOpen access

Twenty Years of Benzimidazole Scaffold Optimization in Antiparasitic Drug Discovery

Martin Kondža iD, Valentina Rezić iD, Doris Drmač

ChemMedChem · 2026

DOI: 10.1002/cmdc.70426 ↗

At a glance

Übersichtsarbeit in ChemMedChem, 2026. Written by Martin Kondža and 2 co-authors. Institution: Faculty of Pharmacy, University of Mostar, Mostar, Bosnia and Herzegovina. Major MEDLINE topics: Benzimidazoles, Drug Discovery, Antiparasitic Agents. 89 references. The full text is freely available in PubMed Central.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

The benzimidazole scaffold occupies a unique position in antiparasitic medicinal chemistry: simple in structure yet extraordinarily versatile in biological action. Over the 20 years since ChemMedChem was established, substituted benzimidazoles have been among the most intensively optimized heterocyclic platforms for treating helminthiasis, malaria, leishmaniasis, and trypanosomiasis. This review surveys structure–activity relationship (SAR) studies published between 2005 and 2025, covering anthelmintic derivatives targeting β‐tubulin in nematodes, cestodes, and trematodes, as well as antiprotozoal scaffolds directed against Plasmodium , Leishmania , and Trypanosoma . We examine how substitutions at N‐1, C‐2, C‐5, and C‐6 modulate target affinity, selectivity, and pharmacokinetic properties, and discuss how growing benzimidazole drug resistance has driven structural innovation. Newly uncovered mechanisms of action, including inhibition of Leishmania mexicana arginase, pteridine reductase, Trypanosoma cruzi cruzain, and Plasmodium falciparum dihydroorotate dehydrogenase, are highlighted alongside classical tubulin‐directed SAR. The review also covers formulation advances and future directions including hybrid molecule design, in silico methods, and repurposing strategies.

Subjects

MeSH terms (MEDLINE)

BenzimidazolesDrug DiscoveryAntiparasitic AgentsStructure-Activity RelationshipAnimalsHumansMolecular StructureDihydroorotate Dehydrogenase

Author keywords

antiparasitic agentsbenzimidazoledrug resistanceneglected tropical diseasesstructure–activity relationships

Substances

BenzimidazolesAntiparasitic AgentsbenzimidazoleDihydroorotate Dehydrogenase

Authors and institutions

  • Faculty of Pharmacy, University of Mostar, Mostar, Bosnia and Herzegovina.

ORCID profiles: Martin Kondža, Valentina Rezić

Cite

APA

Kondža, M., Rezić, V., & Drmač, D. (2026). Twenty Years of Benzimidazole Scaffold Optimization in Antiparasitic Drug Discovery. ChemMedChem. https://doi.org/10.1002/cmdc.70426

Vancouver

Kondža M, Rezić V, Drmač D. Twenty Years of Benzimidazole Scaffold Optimization in Antiparasitic Drug Discovery. ChemMedChem. 2026. doi:10.1002/cmdc.70426

BibTeX
@article{Konda2026,
  author = {Kondža, Martin and Rezić, Valentina and Drmač, Doris},
  title = {Twenty Years of Benzimidazole Scaffold Optimization in Antiparasitic Drug Discovery},
  journal = {ChemMedChem},
  year = {2026},
  doi = {10.1002/cmdc.70426}
}
Start for free →